Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms RSS Feed RSS Feeds


Press Release

Bormioli Rocco Pharma Strengthens Service to North American Market with Dedicated Sales Team

Bormioli Rocco Pharma
Posted on: 14 Sep 17

Bormioli Rocco Pharma, one of the world’s leading glass and plastic manufacturers, is strengthening its services in North America for pharmaceutical glass packaging with a dedicated sales team and innovative products, particularly for high-value parenteral drugs.

This Smart News Release features multimedia. View the full release here:

Bormioli Rocco Pharma is now making its Delta molded Type I glass vials, and complete line of glass and plastic containers and closures, available in North America. (Photo: Business Wire)

A market leader in its home country of Italy and co-leader in Europe, where the company has focused its sales and serves many Top 10 global pharmaceutical, biopharmaceutical and contract manufacturing organizations, Bormioli Rocco Pharma is now making its Delta molded Type I glass vials, and complete line of glass and plastic containers and closures, available in North America.

The company is a U.S. FDA-approved supplier of glass and plastic packaging for the pharma, biopharma, and CMO markets.

“As a validated international supplier of premium-quality glass and plastic pharmaceutical packaging, we are excited to introduce our solutions to North American customers with designated sales support,” said Stéphane Bis, Americas Regional Sales Manager at Bormioli Rocco Pharma. “We bring to the table long-term expertise in injectable pharmaceuticals packaging, as well as a complete range of integrated products matched by flexible, high-attention service.”

Bormioli Rocco Pharma’s Delta high-tech molded glass vials, available in a range of sizes and capacities, are optimal for today’s pharmaceutical injectables. As the pharmaceutical industry expands biologics such as antibodies, oligonucleotides and peptides, the active ingredients are more complex and sensitive, requiring specialized packaging that does not delaminate or leach contaminants. Delta products offer higher hydrolytic resistance and internal surface homogeneity to protect against delamination and ensure product stability.

To learn more about Bormioli Rocco Pharma’s North American sales and service strategy, contact Roberto Santovito, U.S. Sales Area Manager at or +393456486807.

About Bormioli Rocco Pharma

Bormioli Rocco Pharma exclusively serves the pharmaceutical and biopharmaceutical market with integrated glass and plastic containers, closures and accessories for packaging, using state-of-the-art materials and technologies. This includes transparent and amber bottles in Type I, II, and III glass for a range of dosage forms, as well as child-proof and tamper-evident closures. These products are developed to guarantee drug integrity and improve patient quality of life. Bormioli Rocco Pharma is ISO 9001 and ISO 15378 (GMP) certified and registered with the main international control organizations.

View source version on

Business Wire

Last updated on: 14/09/2017

Site Map | Privacy & Security | Cookies | Terms and Conditions is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.